Please use this identifier to cite or link to this item:
|Title:||Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine|
Caudle, Michael R.
Carson, Ray J.
Telleria, Carlos M.
|Citation:||Bukovsky A., Caudle, Michael R. et al., Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine, Aging, 2009, 1(2), pp.157-181.|
|Abstract:||The immune system plays an important role in immunity (immune surveillance), but also in the regulation of tissue homeostasis (immune physiology). Lessons from the female reproductive tract indicate that immune system related cells, such as intraepithelial T cells and monocyte-derived cells (MDC) in stratified epithelium, interact amongst themselves and degenerate whereas epithelial cells proliferate and differentiate. In adult ovaries, MDC and T cells are present during oocyte renewal from ovarian stem cells. Activated MDC are also associated with follicular development and atresia, and corpus luteum differentiation. Corpus luteum demise resembles rejection of a graft since it is attended by a massive influx of MDC and T cells resulting in parenchymal and vascular regression. Vascular pericytes play important roles in immune physiology, and their activities (including secretion of the Thy-1 differentiation protein) can be regulated by vascular autonomic innervation. In tumors, MDC regulate proliferation of neoplastic cells and angiogenesis. Tumor infiltrating T cells die among malignant cells. Alterations of immune physiology can result in pathology, such as autoimmune, metabolic, and degenerative diseases, but also in infertility and intrauterine growth retardation, fetal morbidity and mortality. Animal experiments indicate that modification of tissue differentiation (retardation or acceleration) during immune adaptation can cause malfunction (persistent immaturity or premature aging) of such tissue during adulthood. Thus successful stem cell therapy will depend on immune physiology in targeted tissues. From this point of view, regenerative medicine is more likely to be successful in acute rather than chronic tissue disorders.|
|Description:||This is the publisher's PDF copy and the paper was published as Aging, 2009, 1(2), pp.157-181. The paper is also available at http://www.impactaging.com/papers/v1/n2/abs/100024a.html.|
|Appears in Collections:||Published Articles, Dept. of Medical and Social Care Education|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.